Kevin J. Mercer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kevin J. Mercer has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Brian Wesley Gilbert
Department of Pharmacy Wesley Medical Center Wichita Kansas USA
2 shared publications - Alicia E. Mattson
Department of Pharmacy and Emergency Medicine, Mayo Clinic Rochester, MN, USA
1 shared publication - Alyssa Robertson
Department of Pharmacy, Wellspan York Hospital, 1001 S George St, York, PA 17403, USA
1 shared publication - Brett Faine
Department of Emergency Medicine and Pharmacy University of Iowa Iowa City Iowa USA
1 shared publication - Caitlin S. Brown
Department of Pharmacy Mayo Clinic Rochester Minnesota USA
1 shared publication - Christian E. Kroll
Department of Pharmacy, Iowa Health Care, 200 Hawkins Dr, Iowa City, IA 52242, USA
1 shared publication
Latest Publications
- 18 August 2025
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 96, 291-292
The missing piece in The Pitt: A call for emergency medicine pharmacist representation
- 18 August 2025
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 96, 291-292
The missing piece in The Pitt: A call for emergency medicine pharmacist representation
- 9 August 2025
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 98, 57-64
Assessing the impact of emergency medicine pharmacists on fibrinolytic door-to-needle times in acute ischemic stroke: A systematic review and meta-analysis (Pharmacist-assisted Stroke Treatments I (PhAST-1))
- 9 August 2025
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 98, 57-64
Assessing the impact of emergency medicine pharmacists on fibrinolytic door-to-needle times in acute ischemic stroke: A systematic review and meta-analysis (Pharmacist-assisted Stroke Treatments I (PhAST-1))
- Open Access
- 1 June 2025
- Published by AME Publishing Company in Journal of Emergency and Critical Care Medicine
- Vol. 9, 11
Evaluation of patient outcomes associated with lactated ringers versus normal saline in patients presenting with diabetic ketoacidosis in a multicenter health system
According to American Diabetes Association (ADA) clinical practice guidelines, normal saline (NS) is recommended for treating diabetic ketoacidosis (DKA). However, recent studies have highlighted the benefits of using lactated ringers (LR). The purpose of this study is to compare the clinical outcomes of DKA treatment with LR vs. NS. This is a multicenter, observational, retrospective study of patients with DKA receiving LR vs. NS presenting to community hospital emergency departments within a health-system. In January of 2021, the DKA order set was updated to make LR the fluid of choice for treatment. The LR cohort included patients from January to August 2021 and the NS cohort included patients from January to August 2020. The primary outcome was time to resolution of DKA per ADA clinical practice guidelines. A total of 362 patients were included in the analysis. Among the LR and NS cohorts, there were 136 and 226 patients, respectively. No significant differences were found in race or weight. The LR cohort showed a significant reduction in median time to DKA resolution [14.4 hours, interquartile range (IQR), 11.2–20.7 hours] compared to the NS cohort (17.2 hours; IQR, 11.5–25.9 hours) (P=0.02). Incidence of hyperchloremia did not significantly differ between cohorts. This multicenter evaluation demonstrated that LR reduces time to DKA resolution compared to NS. These findings suggest that LR may provide a more effective treatment option for DKA, potentially leading to faster patient recovery and reduced hospital stays. Further randomized controlled trials are warranted to confirm these findings and assess their impact on patient outcomes.
- 1 June 2025
- Published by AME Publishing Company in Journal of Emergency and Critical Care Medicine
- Vol. 9, 11
Open AccessEvaluation of patient outcomes associated with lactated ringers versus normal saline in patients presenting with diabetic ketoacidosis in a multicenter health system
According to American Diabetes Association (ADA) clinical practice guidelines, normal saline (NS) is recommended for treating diabetic ketoacidosis (DKA). However, recent studies have highlighted the benefits of using lactated ringers (LR). The purpose of this study is to compare the clinical outcomes of DKA treatment with LR vs. NS. This is a multicenter, observational, retrospective study of patients with DKA receiving LR vs. NS presenting to community hospital emergency departments within a health-system. In January of 2021, the DKA order set was updated to make LR the fluid of choice for treatment. The LR cohort included patients from January to August 2021 and the NS cohort included patients from January to August 2020. The primary outcome was time to resolution of DKA per ADA clinical practice guidelines. A total of 362 patients were included in the analysis. Among the LR and NS cohorts, there were 136 and 226 patients, respectively. No significant differences were found in race or weight. The LR cohort showed a significant reduction in median time to DKA resolution [14.4 hours, interquartile range (IQR), 11.2–20.7 hours] compared to the NS cohort (17.2 hours; IQR, 11.5–25.9 hours) (P=0.02). Incidence of hyperchloremia did not significantly differ between cohorts. This multicenter evaluation demonstrated that LR reduces time to DKA resolution compared to NS. These findings suggest that LR may provide a more effective treatment option for DKA, potentially leading to faster patient recovery and reduced hospital stays. Further randomized controlled trials are warranted to confirm these findings and assess their impact on patient outcomes.